Vir Biotechnology (VIR) EBT Margin (2018 - 2026)
Vir Biotechnology (VIR) reported EBT Margin of -51273.94% for Q3 2026, up 16631.48 percentage points from -67905.42% a year earlier but down 51307.52 percentage points from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) EBT Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Vir Biotechnology's EBT Margin came in at -60.92%, up 2901.03 percentage points year-over-year; for FY2025, it came in at -638.56%, up 66.39 percentage points from FY2024.
- EBT Margin has a five-year change of -247.54 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -704.95% in FY2024 (+23.99 pp), -728.93% in FY2023 (-775.61 pp), 46.68% in FY2022 (-3.51 pp) and 50.19% in FY2021 (+441.21 pp).
- Five-year quarterly EBT Margin spans a low of -432844.83% in Q1 2026 and a high of 74.80% in Q1 2022.
- Year over year, EBT Margin gained in three of the last eight quarters, with an average year-over-year change of -58724.52 percentage points.
- The high point for year-over-year EBT Margin in five years was Q3 2026 (a gain of 16631.48 percentage points); the low point was Q1 2026 (a drop of 428855.74 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 33.59% (Q2 2026), -432844.83% (Q1 2026) and -67.21% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Vir Biotechnology | 2.28 Bn | 363.84 Mn | 188,000.00 | -51,273.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -51,273.94% |
| Jun 30, 2026 | 33.59% |
| Mar 31, 2026 | -432,844.83% |
| Dec 31, 2025 | -67.21% |
| Sep 30, 2025 | -67,905.42% |
| Jun 30, 2025 | -9,125.86% |
| Mar 31, 2025 | -3,989.08% |
| Dec 31, 2024 | -845.93% |
| Sep 30, 2024 | -8,972.27% |
| Jun 30, 2024 | -4,549.27% |
| Mar 31, 2024 | -115.30% |
| Dec 31, 2023 | -719.35% |
| Sep 30, 2023 | -6,313.98% |
| Jun 30, 2023 | -5,204.71% |
| Mar 31, 2023 | -227.44% |
| Dec 31, 2022 | -306.90% |
| Sep 30, 2022 | 58.13% |
| Jun 30, 2022 | -575.26% |
| Mar 31, 2022 | 74.80% |
| Dec 31, 2021 | 67.17% |
API Access
Vir Biotechnology EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();